CN104706998A - 临床护理用治疗过敏性鼻炎的中药喷剂及其制备方法 - Google Patents
临床护理用治疗过敏性鼻炎的中药喷剂及其制备方法 Download PDFInfo
- Publication number
- CN104706998A CN104706998A CN201510072202.1A CN201510072202A CN104706998A CN 104706998 A CN104706998 A CN 104706998A CN 201510072202 A CN201510072202 A CN 201510072202A CN 104706998 A CN104706998 A CN 104706998A
- Authority
- CN
- China
- Prior art keywords
- parts
- traditional chinese
- allergic rhinitis
- chinese medicinal
- herba
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000007921 spray Substances 0.000 title claims abstract description 73
- 206010039085 Rhinitis allergic Diseases 0.000 title claims abstract description 52
- 201000010105 allergic rhinitis Diseases 0.000 title claims abstract description 52
- 239000003814 drug Substances 0.000 title claims abstract description 36
- 238000002360 preparation method Methods 0.000 title claims description 25
- 241000628997 Flos Species 0.000 claims abstract description 66
- 239000002994 raw material Substances 0.000 claims abstract description 36
- 238000011282 treatment Methods 0.000 claims abstract description 35
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 59
- 239000000706 filtrate Substances 0.000 claims description 42
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 36
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 claims description 23
- 238000002156 mixing Methods 0.000 claims description 21
- 239000011435 rock Substances 0.000 claims description 20
- 238000009835 boiling Methods 0.000 claims description 18
- 238000003756 stirring Methods 0.000 claims description 14
- 239000000725 suspension Substances 0.000 claims description 14
- 229940079593 drug Drugs 0.000 claims description 12
- 229910052742 iron Inorganic materials 0.000 claims description 11
- 239000000779 smoke Substances 0.000 claims description 11
- 235000019640 taste Nutrition 0.000 claims description 9
- 235000013305 food Nutrition 0.000 claims description 8
- 238000005352 clarification Methods 0.000 claims description 7
- 238000001035 drying Methods 0.000 claims description 7
- 239000008157 edible vegetable oil Substances 0.000 claims description 7
- 238000002386 leaching Methods 0.000 claims description 7
- 238000011068 loading method Methods 0.000 claims description 7
- 239000000843 powder Substances 0.000 claims description 7
- 238000010791 quenching Methods 0.000 claims description 7
- 239000006228 supernatant Substances 0.000 claims description 7
- 230000008859 change Effects 0.000 claims description 2
- 230000000694 effects Effects 0.000 abstract description 24
- 206010039101 Rhinorrhoea Diseases 0.000 abstract description 3
- 239000000463 material Substances 0.000 abstract description 3
- 244000205574 Acorus calamus Species 0.000 abstract description 2
- 231100000331 toxic Toxicity 0.000 abstract description 2
- 230000002588 toxic effect Effects 0.000 abstract description 2
- 235000006480 Acorus calamus Nutrition 0.000 abstract 1
- 240000004510 Agastache rugosa Species 0.000 abstract 1
- 244000025254 Cannabis sativa Species 0.000 abstract 1
- 241001598107 Imperata Species 0.000 abstract 1
- 244000167230 Lonicera japonica Species 0.000 abstract 1
- 235000017617 Lonicera japonica Nutrition 0.000 abstract 1
- 241000219823 Medicago Species 0.000 abstract 1
- 208000036071 Rhinorrhea Diseases 0.000 abstract 1
- 229940105847 calamine Drugs 0.000 abstract 1
- 229940126678 chinese medicines Drugs 0.000 abstract 1
- 229910052864 hemimorphite Inorganic materials 0.000 abstract 1
- 235000008216 herbs Nutrition 0.000 abstract 1
- 239000004575 stone Substances 0.000 abstract 1
- 235000014692 zinc oxide Nutrition 0.000 abstract 1
- 239000011787 zinc oxide Substances 0.000 abstract 1
- CPYIZQLXMGRKSW-UHFFFAOYSA-N zinc;iron(3+);oxygen(2-) Chemical compound [O-2].[O-2].[O-2].[O-2].[Fe+3].[Fe+3].[Zn+2] CPYIZQLXMGRKSW-UHFFFAOYSA-N 0.000 abstract 1
- 208000001840 Dandruff Diseases 0.000 description 27
- 239000013566 allergen Substances 0.000 description 12
- 239000008280 blood Substances 0.000 description 12
- 210000004369 blood Anatomy 0.000 description 12
- 201000010099 disease Diseases 0.000 description 11
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 11
- 231100000614 poison Toxicity 0.000 description 10
- 239000003440 toxic substance Substances 0.000 description 10
- 206010007247 Carbuncle Diseases 0.000 description 9
- 210000000582 semen Anatomy 0.000 description 9
- 239000000203 mixture Substances 0.000 description 7
- 208000002193 Pain Diseases 0.000 description 6
- 230000036407 pain Effects 0.000 description 6
- 208000024891 symptom Diseases 0.000 description 6
- 206010028748 Nasal obstruction Diseases 0.000 description 5
- 208000001848 dysentery Diseases 0.000 description 5
- 239000012567 medical material Substances 0.000 description 5
- 210000003097 mucus Anatomy 0.000 description 5
- 206010017553 Furuncle Diseases 0.000 description 4
- 208000003251 Pruritus Diseases 0.000 description 4
- 230000003110 anti-inflammatory effect Effects 0.000 description 4
- 230000006870 function Effects 0.000 description 4
- 230000023597 hemostasis Effects 0.000 description 4
- 210000003928 nasal cavity Anatomy 0.000 description 4
- 210000000952 spleen Anatomy 0.000 description 4
- PNEYBMLMFCGWSK-UHFFFAOYSA-N Alumina Chemical compound [O-2].[O-2].[O-2].[Al+3].[Al+3] PNEYBMLMFCGWSK-UHFFFAOYSA-N 0.000 description 3
- 206010003645 Atopy Diseases 0.000 description 3
- 206010051625 Conjunctival hyperaemia Diseases 0.000 description 3
- 241000238740 Dermatophagoides pteronyssinus Species 0.000 description 3
- 206010020772 Hypertension Diseases 0.000 description 3
- 206010061218 Inflammation Diseases 0.000 description 3
- 241001465754 Metazoa Species 0.000 description 3
- 206010028980 Neoplasm Diseases 0.000 description 3
- 208000004880 Polyuria Diseases 0.000 description 3
- 208000025865 Ulcer Diseases 0.000 description 3
- 239000000427 antigen Substances 0.000 description 3
- 102000036639 antigens Human genes 0.000 description 3
- 108091007433 antigens Proteins 0.000 description 3
- 208000010668 atopic eczema Diseases 0.000 description 3
- 230000036772 blood pressure Effects 0.000 description 3
- 235000009508 confectionery Nutrition 0.000 description 3
- 230000035619 diuresis Effects 0.000 description 3
- 208000001780 epistaxis Diseases 0.000 description 3
- 230000004438 eyesight Effects 0.000 description 3
- 230000001965 increasing effect Effects 0.000 description 3
- 208000015181 infectious disease Diseases 0.000 description 3
- 206010022000 influenza Diseases 0.000 description 3
- 230000001737 promoting effect Effects 0.000 description 3
- 108090000623 proteins and genes Proteins 0.000 description 3
- 238000011084 recovery Methods 0.000 description 3
- 230000008961 swelling Effects 0.000 description 3
- 231100000397 ulcer Toxicity 0.000 description 3
- 206010002653 Anosmia Diseases 0.000 description 2
- 241000208173 Apiaceae Species 0.000 description 2
- 206010003011 Appendicitis Diseases 0.000 description 2
- 208000004429 Bacillary Dysentery Diseases 0.000 description 2
- 208000008035 Back Pain Diseases 0.000 description 2
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 2
- 240000001579 Cirsium arvense Species 0.000 description 2
- 235000005918 Cirsium arvense Nutrition 0.000 description 2
- 206010010726 Conjunctival oedema Diseases 0.000 description 2
- 206010011224 Cough Diseases 0.000 description 2
- 201000004624 Dermatitis Diseases 0.000 description 2
- 241000196324 Embryophyta Species 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 2
- 108090000790 Enzymes Proteins 0.000 description 2
- 208000015220 Febrile disease Diseases 0.000 description 2
- 208000004262 Food Hypersensitivity Diseases 0.000 description 2
- 206010016946 Food allergy Diseases 0.000 description 2
- 241000233866 Fungi Species 0.000 description 2
- 206010017915 Gastroenteritis shigella Diseases 0.000 description 2
- 206010019233 Headaches Diseases 0.000 description 2
- 208000032843 Hemorrhage Diseases 0.000 description 2
- NTYJJOPFIAHURM-UHFFFAOYSA-N Histamine Chemical compound NCCC1=CN=CN1 NTYJJOPFIAHURM-UHFFFAOYSA-N 0.000 description 2
- 206010050515 Hyposmia Diseases 0.000 description 2
- 206010062717 Increased upper airway secretion Diseases 0.000 description 2
- UQSXHKLRYXJYBZ-UHFFFAOYSA-N Iron oxide Chemical compound [Fe]=O UQSXHKLRYXJYBZ-UHFFFAOYSA-N 0.000 description 2
- 206010023126 Jaundice Diseases 0.000 description 2
- WRACWYWAPQQRKC-UHFFFAOYSA-N Madasiatic acid Chemical compound C1C(O)C(O)C(C)(C)C2C(O)CC3(C)C4(C)CCC5(C(O)=O)CCC(C)C(C)C5C4=CCC3C21C WRACWYWAPQQRKC-UHFFFAOYSA-N 0.000 description 2
- WYQVAPGDARQUBT-FGWHUCSPSA-N Madecassol Chemical compound O([C@@H]1[C@@H](CO)O[C@H]([C@@H]([C@H]1O)O)OC[C@H]1O[C@H]([C@@H]([C@@H](O)[C@@H]1O)O)OC(=O)[C@]12CC[C@H]([C@@H]([C@H]1C=1[C@@]([C@@]3(CC[C@H]4[C@](C)(CO)[C@@H](O)[C@H](O)C[C@]4(C)[C@H]3CC=1)C)(C)CC2)C)C)[C@@H]1O[C@@H](C)[C@H](O)[C@@H](O)[C@H]1O WYQVAPGDARQUBT-FGWHUCSPSA-N 0.000 description 2
- 206010027514 Metrorrhagia Diseases 0.000 description 2
- 241000475481 Nebula Species 0.000 description 2
- 206010030113 Oedema Diseases 0.000 description 2
- 206010037660 Pyrexia Diseases 0.000 description 2
- 206010057190 Respiratory tract infections Diseases 0.000 description 2
- 206010070834 Sensitisation Diseases 0.000 description 2
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 2
- 241000194017 Streptococcus Species 0.000 description 2
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 2
- 206010052428 Wound Diseases 0.000 description 2
- 208000027418 Wounds and injury Diseases 0.000 description 2
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 2
- 230000002776 aggregation Effects 0.000 description 2
- 238000004220 aggregation Methods 0.000 description 2
- 230000001139 anti-pruritic effect Effects 0.000 description 2
- 239000003908 antipruritic agent Substances 0.000 description 2
- WYQVAPGDARQUBT-XCWYDTOWSA-N asiaticoside Natural products O=C(O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO[C@H]2[C@H](O)[C@H](O)[C@H](O[C@H]3[C@H](O)[C@H](O)[C@@H](O)[C@H](C)O3)[C@@H](CO)O2)O1)[C@@]12[C@@H]([C@@H](C)[C@H](C)CC1)C=1[C@](C)([C@@]3(C)[C@@H]([C@@]4(C)[C@H]([C@@](CO)(C)[C@@H](O)[C@H](O)C4)CC3)CC=1)CC2 WYQVAPGDARQUBT-XCWYDTOWSA-N 0.000 description 2
- 229940022757 asiaticoside Drugs 0.000 description 2
- QCYLIQBVLZBPNK-UHFFFAOYSA-N asiaticoside A Natural products O1C(C(=O)C(C)C)=CC(C)C(C2(C(OC(C)=O)CC34C5)C)C1CC2(C)C3CCC(C1(C)C)C45CCC1OC1OCC(O)C(O)C1O QCYLIQBVLZBPNK-UHFFFAOYSA-N 0.000 description 2
- 238000013475 authorization Methods 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 210000004556 brain Anatomy 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- ZYGHJZDHTFUPRJ-UHFFFAOYSA-N coumarin Chemical compound C1=CC=C2OC(=O)C=CC2=C1 ZYGHJZDHTFUPRJ-UHFFFAOYSA-N 0.000 description 2
- 230000007812 deficiency Effects 0.000 description 2
- 208000002173 dizziness Diseases 0.000 description 2
- 206010013781 dry mouth Diseases 0.000 description 2
- 239000000428 dust Substances 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 239000000796 flavoring agent Substances 0.000 description 2
- 235000019634 flavors Nutrition 0.000 description 2
- 239000012530 fluid Substances 0.000 description 2
- 239000013568 food allergen Substances 0.000 description 2
- 235000020932 food allergy Nutrition 0.000 description 2
- 229930182470 glycoside Natural products 0.000 description 2
- 239000008187 granular material Substances 0.000 description 2
- 230000003179 granulation Effects 0.000 description 2
- 238000005469 granulation Methods 0.000 description 2
- 231100000869 headache Toxicity 0.000 description 2
- 230000035876 healing Effects 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- 208000006750 hematuria Diseases 0.000 description 2
- 208000006454 hepatitis Diseases 0.000 description 2
- AMWRITDGCCNYAT-UHFFFAOYSA-L hydroxy(oxo)manganese;manganese Chemical compound [Mn].O[Mn]=O.O[Mn]=O AMWRITDGCCNYAT-UHFFFAOYSA-L 0.000 description 2
- 235000019559 hyposmia Nutrition 0.000 description 2
- 230000036039 immunity Effects 0.000 description 2
- 230000001939 inductive effect Effects 0.000 description 2
- 230000004054 inflammatory process Effects 0.000 description 2
- 230000007803 itching Effects 0.000 description 2
- 210000003734 kidney Anatomy 0.000 description 2
- 210000004072 lung Anatomy 0.000 description 2
- 208000004396 mastitis Diseases 0.000 description 2
- 235000013336 milk Nutrition 0.000 description 2
- 210000004080 milk Anatomy 0.000 description 2
- 239000008267 milk Substances 0.000 description 2
- 208000010753 nasal discharge Diseases 0.000 description 2
- 210000001331 nose Anatomy 0.000 description 2
- 230000000144 pharmacologic effect Effects 0.000 description 2
- 208000026435 phlegm Diseases 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 230000001047 pyretic effect Effects 0.000 description 2
- 206010039083 rhinitis Diseases 0.000 description 2
- 230000008313 sensitization Effects 0.000 description 2
- 201000005113 shigellosis Diseases 0.000 description 2
- 238000005507 spraying Methods 0.000 description 2
- 210000002784 stomach Anatomy 0.000 description 2
- 238000003786 synthesis reaction Methods 0.000 description 2
- MGSRCZKZVOBKFT-UHFFFAOYSA-N thymol Chemical compound CC(C)C1=CC=C(C)C=C1O MGSRCZKZVOBKFT-UHFFFAOYSA-N 0.000 description 2
- 208000004371 toothache Diseases 0.000 description 2
- 239000011573 trace mineral Substances 0.000 description 2
- 235000013619 trace mineral Nutrition 0.000 description 2
- 230000008673 vomiting Effects 0.000 description 2
- 239000011701 zinc Substances 0.000 description 2
- 229910052725 zinc Inorganic materials 0.000 description 2
- XBZYWSMVVKYHQN-MYPRUECHSA-N (4as,6as,6br,8ar,9r,10s,12ar,12br,14bs)-10-hydroxy-2,2,6a,6b,9,12a-hexamethyl-9-[(sulfooxy)methyl]-1,2,3,4,4a,5,6,6a,6b,7,8,8a,9,10,11,12,12a,12b,13,14b-icosahydropicene-4a-carboxylic acid Chemical compound C1C[C@H](O)[C@@](C)(COS(O)(=O)=O)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@@]5(C(O)=O)CCC(C)(C)C[C@H]5C4=CC[C@@H]3[C@]21C XBZYWSMVVKYHQN-MYPRUECHSA-N 0.000 description 1
- CWVRJTMFETXNAD-FWCWNIRPSA-N 3-O-Caffeoylquinic acid Natural products O[C@H]1[C@@H](O)C[C@@](O)(C(O)=O)C[C@H]1OC(=O)\C=C\C1=CC=C(O)C(O)=C1 CWVRJTMFETXNAD-FWCWNIRPSA-N 0.000 description 1
- 206010000077 Abdominal mass Diseases 0.000 description 1
- 206010063409 Acarodermatitis Diseases 0.000 description 1
- 208000002874 Acne Vulgaris Diseases 0.000 description 1
- 241000251468 Actinopterygii Species 0.000 description 1
- 208000035285 Allergic Seasonal Rhinitis Diseases 0.000 description 1
- 208000006400 Arbovirus Encephalitis Diseases 0.000 description 1
- 208000006820 Arthralgia Diseases 0.000 description 1
- 206010063659 Aversion Diseases 0.000 description 1
- 241000193830 Bacillus <bacterium> Species 0.000 description 1
- 241000193738 Bacillus anthracis Species 0.000 description 1
- 239000004857 Balsam Substances 0.000 description 1
- 241001674044 Blattodea Species 0.000 description 1
- PZIRUHCJZBGLDY-UHFFFAOYSA-N Caffeoylquinic acid Natural products CC(CCC(=O)C(C)C1C(=O)CC2C3CC(O)C4CC(O)CCC4(C)C3CCC12C)C(=O)O PZIRUHCJZBGLDY-UHFFFAOYSA-N 0.000 description 1
- 235000011996 Calamus deerratus Nutrition 0.000 description 1
- 241000282472 Canis lupus familiaris Species 0.000 description 1
- 206010008479 Chest Pain Diseases 0.000 description 1
- 206010008570 Chloasma Diseases 0.000 description 1
- 206010008909 Chronic Hepatitis Diseases 0.000 description 1
- 208000035473 Communicable disease Diseases 0.000 description 1
- 206010010741 Conjunctivitis Diseases 0.000 description 1
- 206010010774 Constipation Diseases 0.000 description 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- 102000004127 Cytokines Human genes 0.000 description 1
- 108090000695 Cytokines Proteins 0.000 description 1
- 206010012373 Depressed level of consciousness Diseases 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 241000255925 Diptera Species 0.000 description 1
- 206010052369 Encephalitis lethargica Diseases 0.000 description 1
- 208000004232 Enteritis Diseases 0.000 description 1
- 201000000297 Erysipelas Diseases 0.000 description 1
- 241000588724 Escherichia coli Species 0.000 description 1
- 241000282326 Felis catus Species 0.000 description 1
- PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical compound FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 description 1
- 208000007882 Gastritis Diseases 0.000 description 1
- 102000003886 Glycoproteins Human genes 0.000 description 1
- 108090000288 Glycoproteins Proteins 0.000 description 1
- 206010054787 Haemorrhoidal haemorrhage Diseases 0.000 description 1
- 239000009636 Huang Qi Substances 0.000 description 1
- 208000008454 Hyperhidrosis Diseases 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- BAHUBXAYVOCLNA-UHFFFAOYSA-N Isoangelol Natural products O1C(=O)C=CC2=C1C=C(OC)C(C(OC(=O)C(C)=CC)C(O)C(C)(C)O)=C2 BAHUBXAYVOCLNA-UHFFFAOYSA-N 0.000 description 1
- 244000303199 Lamium album Species 0.000 description 1
- 235000009199 Lamium album Nutrition 0.000 description 1
- 206010024229 Leprosy Diseases 0.000 description 1
- 206010024264 Lethargy Diseases 0.000 description 1
- 208000008930 Low Back Pain Diseases 0.000 description 1
- 201000005505 Measles Diseases 0.000 description 1
- 208000003351 Melanosis Diseases 0.000 description 1
- 201000009906 Meningitis Diseases 0.000 description 1
- 208000019914 Mental Fatigue Diseases 0.000 description 1
- 241001448624 Miliaria Species 0.000 description 1
- CWVRJTMFETXNAD-KLZCAUPSSA-N Neochlorogenin-saeure Natural products O[C@H]1C[C@@](O)(C[C@@H](OC(=O)C=Cc2ccc(O)c(O)c2)[C@@H]1O)C(=O)O CWVRJTMFETXNAD-KLZCAUPSSA-N 0.000 description 1
- 208000007443 Neurasthenia Diseases 0.000 description 1
- 206010030302 Oliguria Diseases 0.000 description 1
- 208000007117 Oral Ulcer Diseases 0.000 description 1
- 240000007594 Oryza sativa Species 0.000 description 1
- 235000007164 Oryza sativa Nutrition 0.000 description 1
- 206010034038 Parotitis Diseases 0.000 description 1
- 206010034107 Pasteurella infections Diseases 0.000 description 1
- 201000007100 Pharyngitis Diseases 0.000 description 1
- 206010035664 Pneumonia Diseases 0.000 description 1
- 208000037062 Polyps Diseases 0.000 description 1
- 241000220324 Pyrus Species 0.000 description 1
- 208000025747 Rheumatic disease Diseases 0.000 description 1
- 241000607142 Salmonella Species 0.000 description 1
- 241000447727 Scabies Species 0.000 description 1
- 208000034189 Sclerosis Diseases 0.000 description 1
- 206010048908 Seasonal allergy Diseases 0.000 description 1
- 206010040047 Sepsis Diseases 0.000 description 1
- 206010040943 Skin Ulcer Diseases 0.000 description 1
- 241000295644 Staphylococcaceae Species 0.000 description 1
- 206010041925 Staphylococcal infections Diseases 0.000 description 1
- 241000191967 Staphylococcus aureus Species 0.000 description 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 1
- 206010042674 Swelling Diseases 0.000 description 1
- 210000001744 T-lymphocyte Anatomy 0.000 description 1
- 206010043458 Thirst Diseases 0.000 description 1
- 239000005844 Thymol Substances 0.000 description 1
- 206010046306 Upper respiratory tract infection Diseases 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 206010047601 Vitamin B1 deficiency Diseases 0.000 description 1
- 206010047700 Vomiting Diseases 0.000 description 1
- 208000005946 Xerostomia Diseases 0.000 description 1
- 210000001015 abdomen Anatomy 0.000 description 1
- 206010000496 acne Diseases 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 208000026935 allergic disease Diseases 0.000 description 1
- 230000000172 allergic effect Effects 0.000 description 1
- 230000007815 allergy Effects 0.000 description 1
- 230000036592 analgesia Effects 0.000 description 1
- 229930183733 angelol Natural products 0.000 description 1
- 230000001754 anti-pyretic effect Effects 0.000 description 1
- 230000001147 anti-toxic effect Effects 0.000 description 1
- 230000000259 anti-tumor effect Effects 0.000 description 1
- 230000000840 anti-viral effect Effects 0.000 description 1
- 239000002221 antipyretic Substances 0.000 description 1
- 208000002399 aphthous stomatitis Diseases 0.000 description 1
- 125000003118 aryl group Chemical group 0.000 description 1
- 206010003549 asthenia Diseases 0.000 description 1
- 208000019804 backache Diseases 0.000 description 1
- 229910052788 barium Inorganic materials 0.000 description 1
- DSAJWYNOEDNPEQ-UHFFFAOYSA-N barium atom Chemical compound [Ba] DSAJWYNOEDNPEQ-UHFFFAOYSA-N 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 208000002894 beriberi Diseases 0.000 description 1
- 230000002146 bilateral effect Effects 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 230000005540 biological transmission Effects 0.000 description 1
- 235000019636 bitter flavor Nutrition 0.000 description 1
- 235000019658 bitter taste Nutrition 0.000 description 1
- 230000000740 bleeding effect Effects 0.000 description 1
- 208000010217 blepharitis Diseases 0.000 description 1
- 230000023555 blood coagulation Effects 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- BRPQOXSCLDDYGP-UHFFFAOYSA-N calcium oxide Chemical compound [O-2].[Ca+2] BRPQOXSCLDDYGP-UHFFFAOYSA-N 0.000 description 1
- 239000000292 calcium oxide Substances 0.000 description 1
- ODINCKMPIJJUCX-UHFFFAOYSA-N calcium oxide Inorganic materials [Ca]=O ODINCKMPIJJUCX-UHFFFAOYSA-N 0.000 description 1
- OSGAYBCDTDRGGQ-UHFFFAOYSA-L calcium sulfate Chemical compound [Ca+2].[O-]S([O-])(=O)=O OSGAYBCDTDRGGQ-UHFFFAOYSA-L 0.000 description 1
- 239000001569 carbon dioxide Substances 0.000 description 1
- 229910002092 carbon dioxide Inorganic materials 0.000 description 1
- 210000000748 cardiovascular system Anatomy 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 230000032823 cell division Effects 0.000 description 1
- 230000004663 cell proliferation Effects 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 229940074393 chlorogenic acid Drugs 0.000 description 1
- 235000001368 chlorogenic acid Nutrition 0.000 description 1
- CWVRJTMFETXNAD-JUHZACGLSA-N chlorogenic acid Chemical compound O[C@@H]1[C@H](O)C[C@@](O)(C(O)=O)C[C@H]1OC(=O)\C=C\C1=CC=C(O)C(O)=C1 CWVRJTMFETXNAD-JUHZACGLSA-N 0.000 description 1
- FFQSDFBBSXGVKF-KHSQJDLVSA-N chlorogenic acid Natural products O[C@@H]1C[C@](O)(C[C@@H](CC(=O)C=Cc2ccc(O)c(O)c2)[C@@H]1O)C(=O)O FFQSDFBBSXGVKF-KHSQJDLVSA-N 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- BMRSEYFENKXDIS-KLZCAUPSSA-N cis-3-O-p-coumaroylquinic acid Natural products O[C@H]1C[C@@](O)(C[C@@H](OC(=O)C=Cc2ccc(O)cc2)[C@@H]1O)C(=O)O BMRSEYFENKXDIS-KLZCAUPSSA-N 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 210000000795 conjunctiva Anatomy 0.000 description 1
- 239000010949 copper Substances 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- 235000001671 coumarin Nutrition 0.000 description 1
- 229960000956 coumarin Drugs 0.000 description 1
- 238000005034 decoration Methods 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- YWEUIGNSBFLMFL-UHFFFAOYSA-N diphosphonate Chemical compound O=P(=O)OP(=O)=O YWEUIGNSBFLMFL-UHFFFAOYSA-N 0.000 description 1
- 206010014599 encephalitis Diseases 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 206010015037 epilepsy Diseases 0.000 description 1
- 210000002919 epithelial cell Anatomy 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 230000005713 exacerbation Effects 0.000 description 1
- 239000004744 fabric Substances 0.000 description 1
- 230000002550 fecal effect Effects 0.000 description 1
- 210000003608 fece Anatomy 0.000 description 1
- 229930182486 flavonoid glycoside Natural products 0.000 description 1
- 150000007955 flavonoid glycosides Chemical class 0.000 description 1
- 239000011737 fluorine Substances 0.000 description 1
- 229910052731 fluorine Inorganic materials 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 208000003512 furunculosis Diseases 0.000 description 1
- 230000005182 global health Effects 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 150000002338 glycosides Chemical class 0.000 description 1
- 230000012010 growth Effects 0.000 description 1
- 230000020169 heat generation Effects 0.000 description 1
- 208000035861 hematochezia Diseases 0.000 description 1
- 230000002949 hemolytic effect Effects 0.000 description 1
- 231100000283 hepatitis Toxicity 0.000 description 1
- 230000002443 hepatoprotective effect Effects 0.000 description 1
- 241000411851 herbal medicine Species 0.000 description 1
- 229960001340 histamine Drugs 0.000 description 1
- 230000037315 hyperhidrosis Effects 0.000 description 1
- 238000007654 immersion Methods 0.000 description 1
- 230000036737 immune function Effects 0.000 description 1
- 230000028993 immune response Effects 0.000 description 1
- 230000037189 immune system physiology Effects 0.000 description 1
- 230000002458 infectious effect Effects 0.000 description 1
- 208000027866 inflammatory disease Diseases 0.000 description 1
- 238000011221 initial treatment Methods 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 239000002917 insecticide Substances 0.000 description 1
- 230000031891 intestinal absorption Effects 0.000 description 1
- 230000001788 irregular Effects 0.000 description 1
- MWDZOUNAPSSOEL-UHFFFAOYSA-N kaempferol Natural products OC1=C(C(=O)c2cc(O)cc(O)c2O1)c3ccc(O)cc3 MWDZOUNAPSSOEL-UHFFFAOYSA-N 0.000 description 1
- 230000002045 lasting effect Effects 0.000 description 1
- 230000013016 learning Effects 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 208000019423 liver disease Diseases 0.000 description 1
- LRDGATPGVJTWLJ-UHFFFAOYSA-N luteolin Natural products OC1=CC(O)=CC(C=2OC3=CC(O)=CC(O)=C3C(=O)C=2)=C1 LRDGATPGVJTWLJ-UHFFFAOYSA-N 0.000 description 1
- 235000009498 luteolin Nutrition 0.000 description 1
- -1 luteolin glycosides Chemical class 0.000 description 1
- 201000007227 lymph node tuberculosis Diseases 0.000 description 1
- PRAUVHZJPXOEIF-AOLYGAPISA-N madecassic acid Chemical compound C1[C@@H](O)[C@H](O)[C@@](C)(CO)[C@@H]2[C@H](O)C[C@@]3(C)[C@]4(C)CC[C@@]5(C(O)=O)CC[C@@H](C)[C@H](C)[C@H]5C4=CC[C@@H]3[C@]21C PRAUVHZJPXOEIF-AOLYGAPISA-N 0.000 description 1
- PRAUVHZJPXOEIF-UHFFFAOYSA-N madecassica acid Natural products C1C(O)C(O)C(C)(CO)C2C(O)CC3(C)C4(C)CCC5(C(O)=O)CCC(C)C(C)C5C4=CCC3C21C PRAUVHZJPXOEIF-UHFFFAOYSA-N 0.000 description 1
- 239000000395 magnesium oxide Substances 0.000 description 1
- CPLXHLVBOLITMK-UHFFFAOYSA-N magnesium oxide Inorganic materials [Mg]=O CPLXHLVBOLITMK-UHFFFAOYSA-N 0.000 description 1
- AXZKOIWUVFPNLO-UHFFFAOYSA-N magnesium;oxygen(2-) Chemical compound [O-2].[Mg+2] AXZKOIWUVFPNLO-UHFFFAOYSA-N 0.000 description 1
- 206010025482 malaise Diseases 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 210000002850 nasal mucosa Anatomy 0.000 description 1
- 230000001537 neural effect Effects 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 230000009965 odorless effect Effects 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 230000001314 paroxysmal effect Effects 0.000 description 1
- 201000005115 pasteurellosis Diseases 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 235000021017 pears Nutrition 0.000 description 1
- 239000008188 pellet Substances 0.000 description 1
- 230000000149 penetrating effect Effects 0.000 description 1
- DLYUQMMRRRQYAE-UHFFFAOYSA-N phosphorus pentoxide Inorganic materials O1P(O2)(=O)OP3(=O)OP1(=O)OP2(=O)O3 DLYUQMMRRRQYAE-UHFFFAOYSA-N 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 230000008092 positive effect Effects 0.000 description 1
- CHWRSCGUEQEHOH-UHFFFAOYSA-N potassium oxide Chemical compound [O-2].[K+].[K+] CHWRSCGUEQEHOH-UHFFFAOYSA-N 0.000 description 1
- 229910001950 potassium oxide Inorganic materials 0.000 description 1
- 230000035935 pregnancy Effects 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 238000010926 purge Methods 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 230000000306 recurrent effect Effects 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 230000029058 respiratory gaseous exchange Effects 0.000 description 1
- 230000000552 rheumatic effect Effects 0.000 description 1
- 235000009566 rice Nutrition 0.000 description 1
- 208000005687 scabies Diseases 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 208000013223 septicemia Diseases 0.000 description 1
- 239000000377 silicon dioxide Substances 0.000 description 1
- 235000012239 silicon dioxide Nutrition 0.000 description 1
- 210000003491 skin Anatomy 0.000 description 1
- 210000004927 skin cell Anatomy 0.000 description 1
- 206010040872 skin infection Diseases 0.000 description 1
- 231100000019 skin ulcer Toxicity 0.000 description 1
- 206010041232 sneezing Diseases 0.000 description 1
- KKCBUQHMOMHUOY-UHFFFAOYSA-N sodium oxide Chemical compound [O-2].[Na+].[Na+] KKCBUQHMOMHUOY-UHFFFAOYSA-N 0.000 description 1
- 229910001948 sodium oxide Inorganic materials 0.000 description 1
- 235000013599 spices Nutrition 0.000 description 1
- 208000015339 staphylococcus aureus infection Diseases 0.000 description 1
- 229910052712 strontium Inorganic materials 0.000 description 1
- CIOAGBVUUVVLOB-UHFFFAOYSA-N strontium atom Chemical compound [Sr] CIOAGBVUUVVLOB-UHFFFAOYSA-N 0.000 description 1
- 239000011593 sulfur Substances 0.000 description 1
- 229910052717 sulfur Inorganic materials 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 229960000790 thymol Drugs 0.000 description 1
- 239000004408 titanium dioxide Substances 0.000 description 1
- 206010044008 tonsillitis Diseases 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 230000008736 traumatic injury Effects 0.000 description 1
- 201000008827 tuberculosis Diseases 0.000 description 1
- 210000003932 urinary bladder Anatomy 0.000 description 1
- 230000002485 urinary effect Effects 0.000 description 1
- 210000001048 venom Anatomy 0.000 description 1
- 239000002435 venom Substances 0.000 description 1
- 231100000611 venom Toxicity 0.000 description 1
- 201000002498 viral encephalitis Diseases 0.000 description 1
- 239000000341 volatile oil Substances 0.000 description 1
- 210000004916 vomit Anatomy 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
本发明公开了一种临床护理用治疗过敏性鼻炎的中药喷剂,取下述重量配比的主要原料制备而成:金银花10-20份,炉甘石3-9份,藿香3-10份,野菊花6-12份,白茅根3-9份,紫花地丁3-10份,菖蒲5-10份,槐花10-30份,大蓟根3-6份,积雪草15-20份,独活10-30份,麦饭石4-7份。本发明中药制剂基于中医中药治疗过敏性鼻炎的原理,选用的药材制成的中药喷剂,直接作用于患处,能快速的止鼻痒、止流鼻涕,治疗更加全面以清热解毒,快速治疗过敏性鼻炎为主要治疗方向,对过敏性鼻炎有极好的治疗作用。
Description
技术领域
本发明公开了一种中药喷剂,尤其是涉及一种临床护理用治疗过敏性鼻炎的中药喷剂及其制备方法,属中医中药领域。
背景技术
过敏性鼻炎即变应性鼻炎,是指特应性个体接触变应原后,主要由IgE介导的介质(主要是组胺)释放,并有多种免疫活性细胞和细胞因子等参与的鼻黏膜非感染性炎性疾病。其发生的必要条件有3个:特异性抗原即引起机体免疫反应的物质;特应性个体即所谓个体差异、过敏体质;特异性抗原与特应型个体二者相遇。变应性鼻炎是一个全球性健康问题,可导致许多疾病和劳动力丧失。
病因:变应性鼻炎是一种由基因与环境互相作用而诱发的多因素疾病。变应性鼻炎的危险因素可能存在于所有年龄段。1.遗传病因:变应性鼻炎患者具有特应性体质,通常显示出家族聚集性,已有研究发现某些基因与变应性鼻炎相关联。2.变应原暴露:变应原是诱导特异性IgE抗体并与之发生反应的抗原。它们多来源于动物、植物、昆虫、真菌或职业性物质。其成分是蛋白质或糖蛋白,极少数是多聚糖。变应原主要分为吸入性变应原和食物性变应原。吸入性变应原是变应性鼻炎的主要原因。(1)螨在亚热带和热带地区最主要的螨为屋尘螨、粉尘螨等。屋尘螨以人类皮屑为食,并主要生活在床垫、床底、枕头、地毯、家具及绒毛玩具中。在热(20℃以上)且潮湿(相对湿度大于80%)的环境中繁殖最快。屋尘螨变应原包含在其排泄物颗粒中,当沾染的织物被碰动后,这些颗粒便暴露于空气中并能够很快再次沉积下来。空气中的螨变应原浓度与变应性鼻炎的发病有关。(2)花粉风媒花粉由于飘散量巨大且能远距离传输,因而可影响远离花粉源数百公里的人群。虫媒花粉只有直接接触才会致敏,如农艺师和花店店员。花粉的致敏能力随季节、地理位置、温度和植物种类而变化。大多数花粉致敏者会患有结膜炎。(3)动物皮屑动物的皮屑及分泌物携带致敏原。猫、狗变应原在室内尘土和家具装饰中广泛存在。(4)真菌变应原霉菌向室内、外环境中释放变应原性孢子,湿热环境生长迅速。(5)蟑螂变应原变应原见于其粪便及甲壳中,颗粒较大,不在空气中播散。(6)食物变应原在变应性鼻炎不伴有其他系统症状时,食物变态反应少见。另一方面,在患者多个器官受累的情况下,食物变态反应常见。对婴儿来说,多数是由牛奶和大豆引起的;对成人来说常见食物变应原包括:花生、坚果、鱼、鸡蛋、牛奶大豆、苹果、梨等。
临床表现:变应性鼻炎的典型症状主要是阵发性喷嚏、清水样鼻涕、鼻塞和鼻痒。部分伴有嗅觉减退。1.喷嚏:每天数次阵发性发作,每次多于3个,多在晨起或者夜晚或接触过敏原后立刻发作。2.清涕:大量清水样鼻涕,有时可不自觉从鼻孔滴下。3.鼻塞:间歇或持续,单侧或双侧,轻重程度不一。4.鼻痒:大多数患者鼻内发痒,花粉症患者可伴眼痒、耳痒和咽痒。
授权公告号CN 102641394 B(申请号201210138487.0)的中国专利公开了一种治疗过敏性鼻炎的中药组合物,其特征在于它是由下述原料药制成:辛夷20-40份、葶苈子20-40份、蛤蚧10-30份、蝉蜕10-30份、槟榔10-30份、诃子10-20份、石椒草10-20份、五灵脂10-20份、丁香8-15份、黄芪8-15份。授权公告号CN 102552750 B(申请号201210085822.5)的专利公开了一种治疗过敏性鼻炎的中药,其特征在于,其原料药是由以下重量份的药材组成:苇茎30-50份、薏苡仁30-50份、冬瓜子10-20份、桃仁10-20份、梅花30-50份、金银花10-20份、石膏10-20份。
由此可见,中药在治疗过敏性鼻炎方面占有非常重要的地位,但是现存的专利中,大多数是口服液,其起效慢,对于过敏性鼻炎严重的患者不能快速的止痒、止流鼻涕。
发明内容
针对现有治疗过敏性鼻炎的手段不足的现状,本发明的目的之一在于提供临床护理用治疗过敏性鼻炎的中药喷剂,具有易操作、疗效显著的特点,并且它采用地方上较为常见的中药材作为原料,成本低廉。
本发明的另一目的就是提供上述中药喷剂的制备方法。
本发明的上述目的是通过以下技术方案来实现的:
临床护理用治疗过敏性鼻炎的中药喷剂,取下述重量配比的主要原料制备而成:金银花10-20份,炉甘石3-9份,藿香3-10份,野菊花6-12份,白茅根3-9份,紫花地丁3-10份,菖蒲5-10份,槐花10-30份,大蓟根3-6份,积雪草15-20份,独活10-30份,麦饭石4-7份。
临床护理用治疗过敏性鼻炎的中药喷剂,更加优选的方案为,取下述重量配比的主要原料制备而成:金银花12-18份,炉甘石4-7份,藿香5-8份,野菊花8-10份,白茅根4-6份,紫花地丁5-8份,菖蒲6-8份,槐花12-20份,大蓟根4-5份,积雪草16-19份,独活15-25份,麦饭石18-25份。
临床护理用治疗过敏性鼻炎的中药喷剂,更优选的方案为,取下述重量配比的主要原料制备而成:金银花15份,炉甘石6份,藿香6份,野菊花9份,白茅根5份,紫花地丁6份,菖蒲7份,槐花15份,大蓟根4.5份,积雪草17份,独活20份,麦饭石6份。
上述中药喷剂的制备方法,制备步骤如下:
①取干净的炉甘石和麦饭石,打碎,置坩埚内,在无烟的炉火中煅烧至微红,取出,立即倒入水盆中浸淬,搅拌,倾出混悬液,将石渣晾干,再煅烧2-6次,最后将石渣弃去。取混悬液澄清,倒入清水,将滤出的细粉干燥备用;
②将藿香与野菊花置于预热好的容器内,用中火炒至表面深黄色取出,研磨成末备用;
③将白茅根和大蓟根用清水清洗3-7次,置于预热好的铁板上,反复烘制20-40分钟,放凉研磨成细末待用;
④将菖蒲和积雪草洗净沥干水分,取适量食用油置于锅内待锅内四周冒烟时放入沥干水分的菖蒲和积雪草,微炒至深黄色,取出研磨成细末待用;
⑤将金银花、紫花地丁、槐花和独活混匀铺在蒸笼上,喷洒上黄酒,稍焖10-30分钟,小火蒸制出青味,再次均匀喷洒黄酒,蒸30-50分钟,取出烘1-2小时,研磨成细末待用;
⑥步骤①-⑤所得原料药混匀,加入乙醇,并煎煮两次,第一次加原料总重量2-4倍的乙醇,小火慢煨20-40分钟,并且不停的搅拌,过滤,得滤液1,第二次加原料总重量1-3倍的乙醇,大火加热至沸腾,改小火煎煮10-20分钟,过滤,得滤液2,将滤液1与滤液2混匀,得混合滤液,将混合滤液加热至沸腾后,静置10-20小时,取上清液装入密封瓶即得中药喷剂。
上述中药喷剂的制备方法,步骤①将石渣晾干,再煅烧3-5次(优选的,将石渣晾干,再煅烧4次)。
上述中药喷剂的制备方法,步骤③将白茅根和大蓟根用清水清洗4-6次,置于预热好的铁板上,反复烘制25-35分钟(优选的,将白茅根和大蓟根用清水清洗5次,置于预热好的铁板上,反复烘制30分钟)。
上述中药喷剂的制备方法,步骤⑤喷洒上黄酒,稍焖15-25分钟(优选的,喷洒上黄酒,稍焖20分钟)。
上述中药喷剂的制备方法,步骤⑤再次均匀喷洒黄酒,蒸35-45分钟,取出烘1.3-1.8小时(优选的,再次均匀喷洒黄酒,蒸40分钟,取出烘1.5小时)。
上述中药喷剂的制备方法,步骤⑥第一次加原料总重量2.5-3.5倍的乙醇,小火慢煨25-35分钟(优选的,第一次加原料总重量3倍的乙醇,小火慢煨30分钟)。
上述中药喷剂的制备方法,步骤⑥第二次加原料总重量1.5-2.5倍的乙醇,大火加热至沸腾,改小火煎煮13-18分钟(优选的,第二次加原料总重量2倍的乙醇,大火加热至沸腾,改小火煎煮15分钟)。
使用方法:为使本发明达到最佳治疗效果,每次取本发明中药喷剂1-3ml,喷于鼻腔内,一日数次。
该中药组合物对鼻炎效果显著,不仅有通鼻的功效,还能够根治鼻炎之症,同时该中药组合物还具有解毒、化瘀的功效,对于久病而致精神萎靡,神情疲乏者有良好的调治作用。本发明多选用地方常见药材,价格低廉,减轻了患者的经济负担,本发明中药喷剂一般一次性解决,复发性低。一般使用当天明显见效,坚持用药7天病人基本都能痊愈。本发明多选用地方常见药材,价格本发明多选用地方常见药材,价格低廉,减轻了患者的经济负担。
各原料药的药理功效分别为:
金银花:金银花自古以来就以它的药用价值广泛而著名。其功效主要是清热解毒,主治温病发热、热毒血痢、痈疽疔毒等。现代研究证明,金银花含有绿原酸、木犀草素苷等药理活性成分,对溶血性链球菌、金黄葡萄球菌等多种致病菌及上呼吸道感染致病病毒等有较强的抑制力,另外还可增强免疫力、抗早孕、护肝、抗肿瘤、消炎、解热、止血(凝血)、抑制肠道吸收胆固醇等,其临床用途非常广泛,可与其它药物配伍用于治疗呼吸道感染、菌痢、急性泌尿系统感染、高血压等40余种病症。味甘,入肺、心、胃经,具有清热解毒、抗炎、补虚疗风的功效,主治胀满下疾、温病发热,热毒痈疡和肿瘤等症。其对于头昏头晕、口干作渴、多汗烦闷、肠炎、菌痢、麻疹、肺炎、乙脑、流脑、急性乳腺炎、败血症、阑尾炎、皮肤感染、痈疽疔疮、丹毒、腮腺炎、化脓性扁桃体炎等病症均有一定疗效。
炉甘石:本品性状为块状集合体,呈不规则的块状,灰白色或淡红色。表面粉性,无光泽,凹凸不平,多孔,似蜂窝状。体轻,易碎。无臭,味微涩。功能主治:解毒明目退翳,收湿止痒敛疮。用于目赤肿痛,眼缘赤烂,翳膜胬肉,溃疡不敛,脓水淋漓,湿疮,皮肤瘙痒。
藿香:味辛,性温。归经:归脾、胃、肺经。功效:化湿醒脾,辟秽和中,解暑,发表。主治:用于湿阻脾胃、脘腹胀满、湿温初起、呕吐、泄泻、暑湿、发热恶寒、恶寒发热、胸脘满闷等症。
野菊花:野菊的叶、花及全草入药。味苦、辛、凉,清热解毒,疏风散热,散瘀,明目,降血压。防治流行性脑脊髓膜炎,预防流行性感冒、感冒,治疗高血压、肝炎、痢疾、痈疖疗疮都有明显效果。野野菊花的浸液对杀灭孑孓及蝇蛆也非常有效。
白茅根:凉血止血,清热利尿。用于血热吐血,衄血,尿血,热病烦渴,肺热咳嗽,胃热呕吐,湿热黄疸,水肿尿少,热淋涩痛。
紫花地丁:紫花地丁性寒味微苦,有清热解毒的功效。主治黄疸、痢疾、乳腺炎、目赤肿痛、咽炎;外敷治跌打损伤、痈肿、毒蛇咬伤。紫花地丁所含黄酮甙类及有机酸对金色葡萄球菌、猪巴氏杆菌、大肠杆菌、链球菌和沙门氏菌都有较强的抑菌作用。所富集微量元素,对人体内多种酶的活性有作用,对核酸蛋白的合成、免疫过程、细胞繁殖都有直接或间接的作用,可促进上皮细胞修复,使细胞分裂增加,T细胞增高,活性增加,从而对生物体的免疫功能起调节作用,通过酶系统发挥对机体代谢的调节和控制。所含锌可抗病毒,并能刺激抗毒素的合成,提高对传染病的抵抗力。
菖蒲:全株芳香,可作香料或驱蚊虫;茎、叶可入药。【藏药】榜那:块根治流感,,炭疽病,风湿痛;叶、花、花蕾治发热性疼痈、头痛、牙痛《滇省志》。根状茎(白菖蒲):苦、辛,温。化痰,开窍,健脾,利湿。用于癫痫,惊悸健忘,神志不清,湿滞痞胀,泄泻痢疾,风湿疼痛,痈肿疥疮。菖蒲其花、茎香味浓郁,具有开窍、祛痰、散风的功效,可祛疫益智、强身健体。历代中医典籍均把菖蒲根茎作为益智宽胸、聪耳明目、祛湿解毒之药。
槐花:凉血止血,清肝泻火。用于便血,痔血,血痢,崩漏,吐血,衄血,肝热目赤,头痛眩晕。
大蓟根:别名马蓟、虎蓟、猫蓟、刺蓟、山牛蒡、刺蓟菜等。性味功效甘、苦,性偏凉润。功擅凉血,止血,适用于治疗血热妄行所致的多种出血症,如咯血、衄血、崩漏、尿血等;又长于化瘀,消痈肿,生肌排脓。可用于治疗肠风肠痈、痛疡肿毒、疔疮、瘰疬结核等。
积雪草:基原:为双子叶植物伞形科积雪草的干燥全草或带根全草。成分:含多种α-香树脂醇型的三萜成分,其中有积雪草苷、参枯尼苷、异参枯尼苷,羟基积雪草苷,玻热模苷、破热米苷和破热米酸等,以及马达积雪草酸。药性:苦、辛,寒。归肝、脾、肾经。功用主治:清热解毒,利湿消肿。是东方人的长寿药,可益脑提神。研究表明具有滋补、消炎、愈合伤口、利尿通便和镇定作用。对麻风病、溃疡也有疗效,对血液净化及免疫力有激活作用,因其可刺激深层皮肤细胞的更替。它是神经滋补剂,能提高记忆力,减轻精神疲劳;还可降血压,治疗肝病等。
独活:为伞形科当归属植物重齿当归的根。成分:含香豆素类化合物,挥发油,乙酸酯,当归醇,百里香酚。药理:对心血管系统有很重要的作用,有降压的作用,能促进血小板的聚集,具有良好的镇痛和抗炎作用。具有抗光敏的作用,对抵抗肿瘤有显著的疗效,对抗菌消炎也有很重要的作用。药性:苦,微温,辛。归肾、膀胱经。功能主治:祛风胜湿,散寒止痛。
麦饭石:基原:为中酸性火成岩类岩石石英二长斑岩。成分:中华麦饭石主要成分有二氧化硅,氧化铝,氧化铁,氧化亚铁,氧化镁,氧化钙,氧化钠,氧化钾,二氧化钛,五氧化二磷,氧化锰,二氧化碳,以及氟、硫、锶、钡、铜、锌等微量元素。药性:《纲目》:“甘,温,无毒。”功用主治:解毒生肌,祛湿健脾。主治痈疽发背,痤疮,湿疹,脚气,痱子,手指皲裂,黄褐斑,牙痛,口腔溃疡,风湿痹痛,腰背痛,慢性肝炎,胃炎,痢疾,糖尿病,神经衰弱,外伤红肿,高血压病,老年性血管硬化,肿瘤,尿路结石。一般作保健用品。
本发明中药制剂基于中医中药治疗过敏性鼻炎的原理,选用的药材制成的中药喷剂,直接作用于患处,能快速的止鼻痒、止流鼻涕,治疗更加全面以清热解毒,快速治疗过敏性鼻炎为主要治疗方向,对过敏性鼻炎有极好的治疗作用。
具体实施方式
下面结合实施例和实验例详细说明本发明的技术方案,但保护范围不被此限制。
实施例1:临床护理用治疗过敏性鼻炎的中药喷剂,取下述重量配比的主要原料制备而成(每份取10g):金银花10份,炉甘石3份,藿香3份,野菊花6份,白茅根3份,紫花地丁3份,菖蒲5份,槐花10份,大蓟根3份,积雪草15份,独活10份,麦饭石4份。
上述临床护理用治疗过敏性鼻炎的中药喷剂的制备方法,步骤如下:
①取干净的炉甘石和麦饭石,打碎,置坩埚内,在无烟的炉火中煅烧至微红,取出,立即倒入水盆中浸淬,搅拌,倾出混悬液,将石渣晾干,再煅烧2次,最后将石渣弃去。取混悬液澄清,倒入清水,将滤出的细粉干燥备用;
②将藿香与野菊花置于预热好的容器内,用中火炒至表面深黄色取出,研磨成末备用;
③将白茅根和大蓟根用清水清洗3次,置于预热好的铁板上,反复烘制20分钟,放凉研磨成细末待用;
④将菖蒲和积雪草洗净沥干水分,取适量食用油置于锅内待锅内四周冒烟时放入沥干水分的菖蒲和积雪草,微炒至深黄色,取出研磨成细末待用;
⑤将金银花、紫花地丁、槐花和独活混匀铺在蒸笼上,喷洒上黄酒,稍焖10分钟,小火蒸制出青味,再次均匀喷洒黄酒,蒸30分钟,取出烘1-2小时,研磨成细末待用;
⑥步骤①-⑤所得原料药混匀,加入乙醇,并煎煮两次,第一次加原料总重量2倍的乙醇,小火慢煨20分钟,并且不停的搅拌,过滤,得滤液1,第二次加原料总重量1倍的乙醇,大火加热至沸腾,改小火煎煮10分钟,过滤,得滤液2,将滤液1与滤液2混匀,得混合滤液,将混合滤液加热至沸腾后,静置10小时,取上清液装入密封瓶即得中药喷剂。
典型病例一:赵XX,男,15岁,山东省济宁邹城市。17岁,鼻痒、鼻塞、流涕、喷嚏3年,经多方治疗无效,遇风则症状加重,口干口苦,舌质红,苔黄,家人非常的害怕带患者去医院检查,经医院诊断为过敏性鼻炎。
使用实施例1所得中药喷剂,每次取本发明中药喷剂1ml,喷于鼻腔内,5天患者痊愈,出院后一直没有复发。
实施例2:临床护理用治疗过敏性鼻炎的中药喷剂,取下述重量配比的主要原料制备而成(每份取10g):金银花20份,炉甘石9份,藿香10份,野菊花12份,白茅根9份,紫花地丁10份,菖蒲10份,槐花30份,大蓟根6份,积雪草20份,独活30份,麦饭石7份。
上述临床护理用治疗过敏性鼻炎的中药喷剂的制备方法,步骤如下:
①取干净的炉甘石和麦饭石,打碎,置坩埚内,在无烟的炉火中煅烧至微红,取出,立即倒入水盆中浸淬,搅拌,倾出混悬液,将石渣晾干,再煅烧6次,最后将石渣弃去。取混悬液澄清,倒入清水,将滤出的细粉干燥备用;
②将藿香与野菊花置于预热好的容器内,用中火炒至表面深黄色取出,研磨成末备用;
③将白茅根和大蓟根用清水清洗7次,置于预热好的铁板上,反复烘制40分钟,放凉研磨成细末待用;
④将菖蒲和积雪草洗净沥干水分,取适量食用油置于锅内待锅内四周冒烟时放入沥干水分的菖蒲和积雪草,微炒至深黄色,取出研磨成细末待用;
⑤将金银花、紫花地丁、槐花和独活混匀铺在蒸笼上,喷洒上黄酒,稍焖30分钟,小火蒸制出青味,再次均匀喷洒黄酒,蒸50分钟,取出烘2小时,研磨成细末待用;
⑥步骤①-⑤所得原料药混匀,加入乙醇,并煎煮两次,第一次加原料总重量4倍的乙醇,小火慢煨40分钟,并且不停的搅拌,过滤,得滤液1,第二次加原料总重量3倍的乙醇,大火加热至沸腾,改小火煎煮20分钟,过滤,得滤液2,将滤液1与滤液2混匀,得混合滤液,将混合滤液加热至沸腾后,静置20小时,取上清液装入密封瓶即得中药喷剂。
实施例3:临床护理用治疗过敏性鼻炎的中药喷剂,取下述重量配比的主要原料制备而成(每份取10g):金银花12份,炉甘石4份,藿香5份,野菊花8份,白茅根4份,紫花地丁5份,菖蒲6份,槐花12份,大蓟根4份,积雪草16份,独活15份,麦饭石18份。
上述临床护理用治疗过敏性鼻炎的中药喷剂的制备方法,步骤如下:
①取干净的炉甘石和麦饭石,打碎,置坩埚内,在无烟的炉火中煅烧至微红,取出,立即倒入水盆中浸淬,搅拌,倾出混悬液,将石渣晾干,再煅烧3次,最后将石渣弃去。取混悬液澄清,倒入清水,将滤出的细粉干燥备用;
②将藿香与野菊花置于预热好的容器内,用中火炒至表面深黄色取出,研磨成末备用;
③将白茅根和大蓟根用清水清洗4次,置于预热好的铁板上,反复烘制25分钟,放凉研磨成细末待用;
④将菖蒲和积雪草洗净沥干水分,取适量食用油置于锅内待锅内四周冒烟时放入沥干水分的菖蒲和积雪草,微炒至深黄色,取出研磨成细末待用;
⑤将金银花、紫花地丁、槐花和独活混匀铺在蒸笼上,喷洒上黄酒,稍焖15分钟,小火蒸制出青味,再次均匀喷洒黄酒,蒸35分钟,取出烘1.3小时,研磨成细末待用;
⑥步骤①-⑤所得原料药混匀,加入乙醇,并煎煮两次,第一次加原料总重量2.5倍的乙醇,小火慢煨25分钟,并且不停的搅拌,过滤,得滤液1,第二次加原料总重量1.5倍的乙醇,大火加热至沸腾,改小火煎煮13分钟,过滤,得滤液2,将滤液1与滤液2混匀,得混合滤液,将混合滤液加热至沸腾后,静置13小时,取上清液装入密封瓶即得中药喷剂。
典型病例二:严XX,女,29岁,山东省枣庄市山亭区。症状:过敏性鼻炎3年,每因接触冷空气和刺激性气味而加重,鼻塞,打喷嚏,大量清水鼻涕,鼻痒,气短懒言,时有畏风怕冷,舌质淡、苔薄,舌下脉络紫暗,脉弱。
使用实施例3所得中药喷剂,每次取本发明中药喷剂2ml,喷于鼻腔内,2天患者症状改善,经过反复喷射药物7天患者痊愈,一直没有在复发。
实施例4:临床护理用治疗过敏性鼻炎的中药喷剂,取下述重量配比的主要原料制备而成(每份取10g):金银花18份,炉甘石7份,藿香8份,野菊花10份,白茅根6份,紫花地丁8份,菖蒲8份,槐花20份,大蓟根5份,积雪草19份,独活25份,麦饭石25份。
上述临床护理用治疗过敏性鼻炎的中药喷剂的制备方法,步骤如下:
①取干净的炉甘石和麦饭石,打碎,置坩埚内,在无烟的炉火中煅烧至微红,取出,立即倒入水盆中浸淬,搅拌,倾出混悬液,将石渣晾干,再煅烧5次,最后将石渣弃去。取混悬液澄清,倒入清水,将滤出的细粉干燥备用;
②将藿香与野菊花置于预热好的容器内,用中火炒至表面深黄色取出,研磨成末备用;
③将白茅根和大蓟根用清水清洗6次,置于预热好的铁板上,反复烘制35分钟,放凉研磨成细末待用;
④将菖蒲和积雪草洗净沥干水分,取适量食用油置于锅内待锅内四周冒烟时放入沥干水分的菖蒲和积雪草,微炒至深黄色,取出研磨成细末待用;
⑤将金银花、紫花地丁、槐花和独活混匀铺在蒸笼上,喷洒上黄酒,稍焖25分钟,小火蒸制出青味,再次均匀喷洒黄酒,蒸45分钟,取出烘1.8小时,研磨成细末待用;
⑥步骤①-⑤所得原料药混匀,加入乙醇,并煎煮两次,第一次加原料总重量3.5倍的乙醇,小火慢煨35分钟,并且不停的搅拌,过滤,得滤液1,第二次加原料总重量2.5倍的乙醇,大火加热至沸腾,改小火煎煮18分钟,过滤,得滤液2,将滤液1与滤液2混匀,得混合滤液,将混合滤液加热至沸腾后,静置18小时,取上清液装入密封瓶即得中药喷剂。
典型病例三 林XX,男,17岁,山东济宁市市中区唐口街。症状:经常不明原因鼻塞,流清水涕,鼻痒,喉部不适,伴有轻微炎症,咳嗽,嗅觉失灵,去医院治疗过很多次,效果均不理想,严重影响了正常的学习生活。
使用实施例4所得中药喷剂,每次取本发明中药喷剂3ml,喷于鼻腔内,2天患者症状改善,经过反复喷射药物7天患者痊愈,一直没有在复发。
实施例5:临床护理用治疗过敏性鼻炎的中药喷剂,取下述重量配比的主要原料制备而成(每份取10g):金银花15份,炉甘石6份,藿香6份,野菊花9份,白茅根5份,紫花地丁6份,菖蒲7份,槐花15份,大蓟根4.5份,积雪草17份,独活20份,麦饭石6份。
上述临床护理用治疗过敏性鼻炎的中药喷剂的制备方法,步骤如下:
①取干净的炉甘石和麦饭石,打碎,置坩埚内,在无烟的炉火中煅烧至微红,取出,立即倒入水盆中浸淬,搅拌,倾出混悬液,将石渣晾干,再煅烧4次,最后将石渣弃去。取混悬液澄清,倒入清水,将滤出的细粉干燥备用;
②将藿香与野菊花置于预热好的容器内,用中火炒至表面深黄色取出,研磨成末备用;
③将白茅根和大蓟根用清水清洗5次,置于预热好的铁板上,反复烘制30分钟,放凉研磨成细末待用;
④将菖蒲和积雪草洗净沥干水分,取适量食用油置于锅内待锅内四周冒烟时放入沥干水分的菖蒲和积雪草,微炒至深黄色,取出研磨成细末待用;
⑤将金银花、紫花地丁、槐花和独活混匀铺在蒸笼上,喷洒上黄酒,稍焖20分钟,小火蒸制出青味,再次均匀喷洒黄酒,蒸40分钟,取出烘1.5小时,研磨成细末待用;
⑥步骤①-⑤所得原料药混匀,加入乙醇,并煎煮两次,第一次加原料总重量3倍的乙醇,小火慢煨30分钟,并且不停的搅拌,过滤,得滤液1,第二次加原料总重量2倍的乙醇,大火加热至沸腾,改小火煎煮15分钟,过滤,得滤液2,将滤液1与滤液2混匀,得混合滤液,将混合滤液加热至沸腾后,静置15小时,取上清液装入密封瓶即得中药喷剂。
实验例:为了验证本发明中药喷剂的效果,我们在4所医院选取了400名过敏性鼻炎患者,进行了药物的实验(实施例5),并精确的对数据进行了统计和数理分析。具体实验结果如下表:
表1
表2:
本发明中药喷剂与其它治疗过敏性鼻炎的药物相比副作用小,本发明中药喷剂在使用初期就能迅速缓解鼻塞、头脑沉重的不适症状,增加患者治愈疾病的信心,且造价低廉,普通百姓长期使用,也不会增加身体和金钱上的负担,且能够真正的根治过敏性鼻炎,使过敏性鼻炎的治愈不再是可求而不可得的,是目前治疗过敏性鼻炎最为理想安全的中药喷剂。
Claims (10)
1.临床护理用治疗过敏性鼻炎的中药喷剂,其特征在于:取下述重量配比的主要原料制备而成:金银花10-20份,炉甘石3-9份,藿香3-10份,野菊花6-12份,白茅根3-9份,紫花地丁3-10份,菖蒲5-10份,槐花10-30份,大蓟根3-6份,积雪草15-20份,独活10-30份,麦饭石4-7份。
2.根据权利要求1所述临床护理用治疗过敏性鼻炎的中药喷剂,其特征在于:取下述重量配比的主要原料制备而成:金银花12-18份,炉甘石4-7份,藿香5-8份,野菊花8-10份,白茅根4-6份,紫花地丁5-8份,菖蒲6-8份,槐花12-20份,大蓟根4-5份,积雪草16-19份,独活15-25份,麦饭石18-25份。
3.根据权利要求1所述临床护理用治疗过敏性鼻炎的中药喷剂,其特征在于:取下述重量配比的主要原料制备而成:金银花15份,炉甘石6份,藿香6份,野菊花9份,白茅根5份,紫花地丁6份,菖蒲7份,槐花15份,大蓟根4.5份,积雪草17份,独活20份,麦饭石6份。
4.根据权利要求1-3任一项所述临床护理用治疗过敏性鼻炎的中药喷剂的制备方法,其特征在于:步骤如下:
①取干净的炉甘石和麦饭石,打碎,置坩埚内,在无烟的炉火中煅烧至微红,取出,立即倒入水盆中浸淬,搅拌,倾出混悬液,将石渣晾干,再煅烧2-6次,最后将石渣弃去。取混悬液澄清,倒入清水,将滤出的细粉干燥备用;
②将藿香与野菊花置于预热好的容器内,用中火炒至表面深黄色取出,研磨成末备用;
③将白茅根和大蓟根用清水清洗3-7次,置于预热好的铁板上,反复烘制20-40分钟,放凉研磨成细末待用;
④将菖蒲和积雪草洗净沥干水分,取适量食用油置于锅内待锅内四周冒烟时放入沥干水分的菖蒲和积雪草,微炒至深黄色,取出研磨成细末待用;
⑤将金银花、紫花地丁、槐花和独活混匀铺在蒸笼上,喷洒上黄酒,稍焖10-30分钟,小火蒸制出青味,再次均匀喷洒黄酒,蒸30-50分钟,取出烘1-2小时,研磨成细末待用;
⑥步骤①-⑤所得原料药混匀,加入乙醇,并煎煮两次,第一次加原料总重量2-4倍的乙醇,小火慢煨20-40分钟,并且不停的搅拌,过滤,得滤液1,第二次加原料总重量1-3倍的乙醇,大火加热至沸腾,改小火煎煮10-20分钟,过滤,得滤液2,将滤液1与滤液2混匀,得混合滤液,将混合滤液加热至沸腾后,静置10-20小时,取上清液装入密封瓶即得中药喷剂。
5.根据权利要求4所述中药喷剂的制备方法,其特征在于:步骤①将石渣晾干,再煅烧3-5次(优选的,将石渣晾干,再煅烧4次)。
6.根据权利要求4所述中药喷剂的制备方法,其特征在于:步骤③将白茅根和大蓟根用清水清洗4-6次,置于预热好的铁板上,反复烘制25-35分钟(优选的,将白茅根和大蓟根用清水清洗5次,置于预热好的铁板上,反复烘制30分钟)。
7.根据权利要求4所述中药喷剂的制备方法,其特征在于:步骤⑤喷洒上黄酒,稍焖15-25分钟(优选的,喷洒上黄酒,稍焖20分钟)。
8.根据权利要求4所述中药喷剂的制备方法,其特征在于:步骤⑤再次均匀喷洒黄酒,蒸35-45分钟,取出烘1.3-1.8小时(优选的,再次均匀喷洒黄酒,蒸40分钟,取出烘1.5小时)。
9.根据权利要求4所述中药喷剂的制备方法,其特征在于:步骤⑥第一次加原料总重量2.5-3.5倍的乙醇,小火慢煨25-35分钟(优选的,第一次加原料总重量3倍的乙醇,小火慢煨30分钟)。
10.根据权利要求4所述中药喷剂的制备方法,其特征在于:步骤⑥第二次加原料总重量1.5-2.5倍的乙醇,大火加热至沸腾,改小火煎煮13-18分钟(优选的,第二次加原料总重量2倍的乙醇,大火加热至沸腾,改小火煎煮15分钟)。
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201510072202.1A CN104706998A (zh) | 2015-02-11 | 2015-02-11 | 临床护理用治疗过敏性鼻炎的中药喷剂及其制备方法 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201510072202.1A CN104706998A (zh) | 2015-02-11 | 2015-02-11 | 临床护理用治疗过敏性鼻炎的中药喷剂及其制备方法 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN104706998A true CN104706998A (zh) | 2015-06-17 |
Family
ID=53407042
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201510072202.1A Pending CN104706998A (zh) | 2015-02-11 | 2015-02-11 | 临床护理用治疗过敏性鼻炎的中药喷剂及其制备方法 |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN104706998A (zh) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105902910A (zh) * | 2016-06-21 | 2016-08-31 | 刘文峰 | 儿科护理用治疗呼吸道感染的滴剂及其制备方法 |
| CN114470024A (zh) * | 2022-03-22 | 2022-05-13 | 杨鑫 | 一种用于治疗鼻炎的草药鸡蛋及其制备方法 |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102670683A (zh) * | 2012-05-22 | 2012-09-19 | 王瑞台 | 一种治疗过敏性鼻炎的中药组合物 |
| CN104042814A (zh) * | 2014-06-25 | 2014-09-17 | 梁黎明 | 一种治疗过敏性鼻炎的中药组合物 |
-
2015
- 2015-02-11 CN CN201510072202.1A patent/CN104706998A/zh active Pending
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102670683A (zh) * | 2012-05-22 | 2012-09-19 | 王瑞台 | 一种治疗过敏性鼻炎的中药组合物 |
| CN104042814A (zh) * | 2014-06-25 | 2014-09-17 | 梁黎明 | 一种治疗过敏性鼻炎的中药组合物 |
Non-Patent Citations (1)
| Title |
|---|
| 黄泰康 主编: "《中医疑难病方药手册》", 31 December 1994 * |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105902910A (zh) * | 2016-06-21 | 2016-08-31 | 刘文峰 | 儿科护理用治疗呼吸道感染的滴剂及其制备方法 |
| CN114470024A (zh) * | 2022-03-22 | 2022-05-13 | 杨鑫 | 一种用于治疗鼻炎的草药鸡蛋及其制备方法 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN1201668C (zh) | 一种保健凉茶及其制作方法 | |
| CN102451356A (zh) | 中草药感冒茶 | |
| CN104208245B (zh) | 手足癣中药药浴及制备方法 | |
| CN104857290A (zh) | 一种治疗烧烫伤的中药消毒膏及其制备方法 | |
| CN103751568B (zh) | 一种治疗瘙痒症的中药组合物及其制备方法 | |
| CN102805805A (zh) | 一种治疗鼻炎的药物及其制备方法 | |
| CN104706998A (zh) | 临床护理用治疗过敏性鼻炎的中药喷剂及其制备方法 | |
| CN106035427A (zh) | 检验科杀菌消毒中药组合物及制备方法 | |
| CN101342331B (zh) | 治疗肺炎和上呼吸道感染的中药喷剂 | |
| CN105250385A (zh) | 一种治疗婴幼儿鼻塞的滴鼻剂 | |
| CN105920380A (zh) | 一种治疗感染黄病毒科的血液细胞修复中药 | |
| CN105456708A (zh) | 一种用于治疗口唇炎的药物及其制备方法 | |
| CN104667086A (zh) | 一种治疗慢性肺炎的中药制剂 | |
| CN105056078A (zh) | 一种治疗胃火炽盛牙痛口臭的中药组合物 | |
| CN104857084A (zh) | 一种治疗小儿外感发热的中药药浴方剂 | |
| CN104474523A (zh) | 一种治疗痰热蕴肺型支原体肺炎的药物及其制备方法 | |
| CN105521235A (zh) | 一种止痒药液 | |
| CN103341151A (zh) | 用于治疗慢性支气管炎的中药 | |
| KR20130014768A (ko) | 소아 아토피 치료용 한약 조성물 및 이의 제조방법 | |
| CN107669784A (zh) | 一种防治与治疗鼻敏感及鼻窦炎的中药使用方法及生产工艺 | |
| CN107137689A (zh) | 一种治疗更年期综合征的中药组合物 | |
| CN104887808A (zh) | 一种治疗牙周炎的中药制剂 | |
| CN104906416B (zh) | 一种用于治疗阴虚火旺型紫癜的中药组合物 | |
| CN105617095A (zh) | 一种用于小儿急性上呼吸道感染的口服液及制备方法 | |
| CN105749138A (zh) | 一种治疗鼻炎的中药滴液及其制备方法 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20150617 |